Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 164(11): 5596-604, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10820234

ABSTRACT

The VH4 genes expressed by both resting and in vivo-activated subepithelial (SE) B cells from human tonsils were studied. Resting SE B cells were subdivided according to the presence (IgDlow) or absence (IgM-only) of surface IgD. CD27 was abundant on activated SE B cells and low on resting IgM-only B cells. Resting IgDlow SE B cells could be subdivided into CD27low and CD27high cell fractions. Resting IgDlow SE B cells displayed VH4 genes with a substantial number of mutations (13/29 of the molecular clones were mutated), whereas 25/26 of the clones from resting IgM-only SE B cells were unmutated. Moreover, mutated VH4 genes were detected mainly within the CD27high cell fraction of the IgDlow SE B cells. Several identical unmutated VH4DJH sequences (11/32) were found in different molecular clones from resting IgM-only SE B cells, suggesting local cellular expansion. Both unmutated (14/25) and mutated (11/25) sequences were found in mu transcripts of activated SE B cells. Extensive mutation was observed in the gamma transcripts of activated SE B cells. Therefore, SE B cells are heterogeneous, being comprised of B cells with mutated Ig VH4 genes, that are Ag-experienced B cells, and a subset of B cells with unmutated VH4 genes that are either virgin cells or cells driven by Ags that did not induce or select for V gene mutations.


Subject(s)
B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/immunology , Palatine Tonsil/cytology , Palatine Tonsil/immunology , Spleen/cytology , Spleen/immunology , B-Lymphocyte Subsets/metabolism , Child , Child, Preschool , Epithelium , Gene Expression Regulation/immunology , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Germ-Line Mutation/immunology , Germinal Center/cytology , Germinal Center/immunology , Germinal Center/metabolism , Humans , Immunoglobulin D/biosynthesis , Immunoglobulin M/biosynthesis , Immunoglobulin Variable Region/biosynthesis , Immunoglobulin Variable Region/genetics , Immunophenotyping , Interphase/genetics , Interphase/immunology , Lymphocyte Activation/genetics , Molecular Sequence Data , Palatine Tonsil/metabolism , Spleen/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 7/biosynthesis
2.
Blood ; 94(9): 3067-76, 1999 Nov 01.
Article in English | MEDLINE | ID: mdl-10556191

ABSTRACT

This study shows that human postthymic T cells express CD10 when undergoing apoptosis, irrespective of the signal responsible for initiating the apoptotic process. Cells from continuous T-cell lines did not normally express CD10, but became CD10(+) when induced into apoptosis by human immunodeficiency virus (HIV) infection and exposure to CD95 monoclonal antibody, etoposide, or staurosporin. Inhibitors of caspases blocked apoptosis and CD10 expression. Both CD4(+) and CD8(+) T cells purified from normal peripheral blood expressed CD10 on apoptotic induction. CD10 was newly synthesized by the apoptosing cells because its expression was inhibited by exposure to cycloheximide and CD10 mRNA became detectable by reverse transcription-polymerase chain reaction in T cells cultured under conditions favoring apoptosis. To show CD10 on T cells apoptosing in vivo, lymph node and peripheral blood T cells from HIV(+) subjects were used. These suspensions were composed of a substantial, although variable, proportion of apoptosing T cells that consistently expressed CD10. In contrast, CD10(+) as well as spontaneously apoptosing T cells were virtually absent in peripheral blood from normal individuals. Collectively, these observations indicate that CD10 may represent a reliable marker for identifying and isolating apoptosing T cells in vitro and ex vivo and possibly suggest novel functions for surface CD10 in the apoptotic process of lymphoid cells.


Subject(s)
Apoptosis/immunology , Neprilysin/biosynthesis , T-Lymphocytes/immunology , T-Lymphocytes/pathology , Cells, Cultured , Flow Cytometry , HIV Seropositivity/blood , HIV Seropositivity/immunology , Humans , Neprilysin/immunology
3.
Cell Immunol ; 193(1): 80-9, 1999 Apr 10.
Article in English | MEDLINE | ID: mdl-10202115

ABSTRACT

Using immunofluorescence, RT-PCR, and Western blotting, we have demonstrated the ability of human B cells to express CD4. In each of the 10 lymphoblastoid cell lines (LCL) tested there was variable, but definite, proportion of CD4-positive B cells. Expression of CD4 was related to the cell cycle; CD4 was expressed in the G1 phase and continued at later phases of the cell cycle. CD4 was in part internalized and degraded by the LCL B cells. Surface CD4 was associated to lck and its crosslinking resulted in tyrosine phosphorylation. Additional experiments conducted on freshly prepared tonsillar B cells demonstrated that CD4 was expressed by large activated B cells, but not by small resting B cells. However, not all the activated tonsillar B cells had surface CD4 since germinal center cells were CD4-negative. Crosslinking of CD4 on LCL or on tonsillar activated B cells resulted in apoptosis in vitro, a finding that indicates the capacity of CD4 to deliver functional signals to B cells and to play a regulatory function in their physiology. Exposure of CD4 expressing B cells to gp120 under conditions that resulted in CD4 crosslinking also caused apoptosis suggesting some implications for the pathophysiology of AIDS.


Subject(s)
Apoptosis , B-Lymphocytes/physiology , CD4 Antigens/physiology , Lymphocyte Activation , CD4 Antigens/analysis , Cell Cycle , Cell Line , HIV Envelope Protein gp120/physiology , Humans , Lymphocyte Specific Protein Tyrosine Kinase p56(lck)/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...